How A.I. Is Used to Detect Cancer That Doctors Miss
Hungary has become a major testing ground for AI. software to detect cancer, as doctors wonder if technology will replace them in medical jobs.
In a dark room at Bács County Hospital- Kiskun outside Budapest, Dr. Éva Ambrózay, a radiologist with more than two decades of experience, looked at a computer screen showing a patient's mammogram.
Two radiologists had previously stated that the x-ray showed no signs that the patient had breast cancer. But Dr. Ambrózay was closely examining several areas of the scan circled in red, which the artificial intelligence software had flagged as potentially cancerous.
"It's something thing," she said. She quickly ordered that the woman be called back for a biopsy, which will take place within the next week.
Advances in A.I. are beginning to make breakthroughs in breast cancer screening by detecting the signs that doctors miss. So far, the technology is showing an impressive ability to detect cancer at least as well as human radiologists, according to early results and radiologists, in what is one of the most tangible signs yet of how which A.I. can improve public health.
Hungary, which has a strong breast cancer screening program, is one of the largest fields of testing the technology on real patients. At five hospitals and clinics that perform more than 35,000 screenings a year, A.I. systems have been deployed starting in 2021 and now can look for signs of cancer that a radiologist might have overlooked. Clinics and hospitals in the United States, Britain and the European Union are also beginning to test or provide data to help develop the systems.
A.I. usage is growing as the technology has become the center of a Silicon Valley boom, with the release of chatbots like ChatGPT showing how A.I. has a remarkable ability to communicate in human-like prose – sometimes with disturbing results. Built from a similar form used by chatbots that is modeled after the human brain, breast cancer screening technology shows other ways A.I. is seeping into daily life.
Hungary has become a major testing ground for AI. software to detect cancer, as doctors wonder if technology will replace them in medical jobs.
In a dark room at Bács County Hospital- Kiskun outside Budapest, Dr. Éva Ambrózay, a radiologist with more than two decades of experience, looked at a computer screen showing a patient's mammogram.
Two radiologists had previously stated that the x-ray showed no signs that the patient had breast cancer. But Dr. Ambrózay was closely examining several areas of the scan circled in red, which the artificial intelligence software had flagged as potentially cancerous.
"It's something thing," she said. She quickly ordered that the woman be called back for a biopsy, which will take place within the next week.
Advances in A.I. are beginning to make breakthroughs in breast cancer screening by detecting the signs that doctors miss. So far, the technology is showing an impressive ability to detect cancer at least as well as human radiologists, according to early results and radiologists, in what is one of the most tangible signs yet of how which A.I. can improve public health.
Hungary, which has a strong breast cancer screening program, is one of the largest fields of testing the technology on real patients. At five hospitals and clinics that perform more than 35,000 screenings a year, A.I. systems have been deployed starting in 2021 and now can look for signs of cancer that a radiologist might have overlooked. Clinics and hospitals in the United States, Britain and the European Union are also beginning to test or provide data to help develop the systems.
A.I. usage is growing as the technology has become the center of a Silicon Valley boom, with the release of chatbots like ChatGPT showing how A.I. has a remarkable ability to communicate in human-like prose – sometimes with disturbing results. Built from a similar form used by chatbots that is modeled after the human brain, breast cancer screening technology shows other ways A.I. is seeping into daily life.
What's Your Reaction?